Study Suggests Many Older Men with BPH May Not Need Long-Term Tamsulosin
A recent clinical trial indicates that approximately one-third of older men receiving tamsulosin for benign prostatic hyperplasia (BPH) may experience minimal symptomatic benefit from continued long-term use. These findings suggest that individualized strategies for deprescribing could help reduce unnecessary medication exposure. The research highlights the importance of periodically reassessing long-term tamsulosin therapy.
Want more?
Open NewsSnap.ai for the full app experience, including audio, personalization, and more news tools.